adepthera2023

Name: adepthera2023 - AI Visibility Score
Creator: Engagemii
Published: 2026-07-07T03:09:27.791Z
License: https://creativecommons.org/licenses/by/4.0/

Unclaimed

⚠ Identity mismatch

AEO Score: 6/10

Monitoring for AI engine activity

In the Engagemii AEO index

adepthera.com

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. adepthera2023 just got measured.

6/10 means adepthera2023 is somewhat visible. AI bots can read you, but you are missing the structured signals that would push citation rate above competitors.

About adepthera2023

Despite recent advances in medicine, there remains a high need for innovative medicines to treat various metabolic, cardiovascular, and pain disorders. Adpethera is filling this gap by developing highly specific and efficient therapies using unique self-assemble peptide analogs. Adepthera is a preclinical stage company, and our lead self-assembling peptide assets are in the IND-enabling stage of development for the treatment of osteoarthritis pain, chronic migraines, and diabetic ulcers.

Key Topics

ADEPTHERA

Adepthera is advancing the field of long-acting peptide therapeutics through its leading scientific work on self-assembling slow-release peptides for GPCR regulation. Our innovative approach integrates foundational science with innovative analogs to deliver new classes of peptide therapeutics for patients who suffer endothelial dysfunction, chronic wounds, and chronic pains. Our team of experienced drug developers is working to launch a new world of innovative peptidomimetic drugs.